Ten year follow up of ulcerative colitis patients with and without low grade dysplasia

Gut

Volumn 52, Issue 8, 2003, Pages 1127-1132

  Lim, C H ^a   Dixon, M F ^b   Vail, A ^c   Forman, D ^b   Lynch, D A F ^d   Axon, A T R ^a  

^a LEEDS GENERAL INFIRMARY   (United Kingdom)

^b UNIVERSITY OF LEEDS   (United Kingdom)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

^d ROYAL BLACKBURN HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RISK; CANCER STAGING; COLON RESECTION; COLONOSCOPY; COLORECTAL CARCINOMA; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DYSPLASIA; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROCTOCOLECTOMY; PROPHYLAXIS; RISK FACTOR; SURVIVAL; ULCERATIVE COLITIS;

ADULT; AGED; COHORT STUDIES; COLECTOMY; COLITIS, ULCERATIVE; COLORECTAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 0037961172     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.52.8.1127     Document Type: Article

References (31)

1. de Dombal FT, Watts JM, Watkinson G, et al. Local complications of ulcerative colitis: stricture, pseudopolyposis, and carcinoma of colon and rectum. BMJ 1966;5501:1442-7.
2. Langholz E, Munkholm P, Davidsen M, et al. Colorectal cancer risk and mortality in patients with ulcerative colitis. Gastroenterology 1992;103:1444-51.
3. Greenstein AJ, Sachar DB, Smith H, et al. Cancer in universal and left-sided ulcerative colitis: factors determining risk. Gastroenterology 1979;77:290-4.
4. Eaden JA, Abrams KR, Mayberry JF. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut 2001;48:526-35.
5. Devroede G, Taylor WF. On calculating cancer risk and survival of ulcerative colitis patients with the life table method. Gastroenterology 1976;71:505-9.
6. Morson BC, Pang LS. Rectal biopsy as an aid to cancer control in ulcerative colitis. Gut 1967;8:423-34.
7. Myrvold HE, Kock NG, Ahren C. Rectal biopsy and precancer in ulcerative colitis. Gut 1974;15:301-4.
8. Blackstone MO, Riddell RH, Rogers BH, et al. Dysplasia-associated lesion or mass (DALM) detected by colonoscopy in long-standing ulcerative colitis: an indication for colectomy. Gastroenterology 1981;80:366-74.
9. Lennard-Jones JE, Morson BC, Ritchie JK, et al. Cancer surveillance in ulcerative colitis. Experience over 15 years. Lancet 1983;2:149-52.
10. Woolrich AJ, DaSilva MD, Korelitz BI. Surveillance in the routine management of ulcerative calitis: the predictive value of low-grade dysplasio. Gastroenterology 1992;103:431-8.
11. Bernstein CN, Shanahan F, Weinstein WM. Are we telling patients the truth about surveillance colonoscopy in ulcerative colitis? Lancet 1994;343:71-4.
12. Eaden JA, Mayberry JF. Guidelines for screening and surveillance of asymptomatic colorectal cancer in patients with inflammatory bowel disease. Gut 2002;51 (suppl 5):V10-12.
13. Lynch DA, Lobo AJ, Sobala GM, et al. Failure of colonoscopic surveillance in ulcerative colitis. Gut 1993;34:1075-80.
14. Eaden J, Abrams K, McKay H, et al. Inter-observer variation between generol and specialist gastrointestinal pathologists when grading dysplasia in ulcerative colitis. J Pathol 2001;194:152-7.
15. Dixon MF, Brown LJ, Gilmour HM, et al. Observer variation in the assessment of dysplasia in ulcerative colitis. Histopathology 1988;13:385-97.
16. Svanholm H, Starklint H, Gundersen HJ, et al. Reproducibility of histomorphologic diagnoses with special reference to the kappa statistic. APMIS 1989;97:689-98.
17. Brostrom O, Lofberg R, Ost A, et al. Cancer surveillance of patients with longstanding ulcerative colitis: a clinical, endoscopical, and histological study. Gut 1986;27:1408-13.
18. Lashner BA, Silverstein MD, Hanauer SB. Hazard rates for dysplasia and cancer in ulcerative colitis. Results from a surveillance program. Dig Dis Sci 1989;34:1536-41.
19. Leidenius M, Kellokumpu I, Husa A, et al. Dysplasia and carcinoma in longstanding ulcerative colitis: an endoscopic and histological surveillance programme. Gut 1991;32:1521-5.
20. Lennard-Jones JE, Melville DM, Morson BC, et al. Precancer and cancer in extensive ulcerative colitis: findings among 401 patients over 22 years. Gut 1990;31:800-6.
21. Lofberg R, Brostrom O, Karlen P, et al. Colonoscopic surveillance in long-standing total ulcerative colitis - a 15-year follow-up study. Gastroenterology 1990;99:1021-31.
22. Nugent FW, Haggitt RC, Gilpin PA. Cancer surveillance in ulcerative colitis. Gastroenterology 1991;100:1241-8.
23. Rutegard J, Ahsgren L, Stenling R, et al. Ulcerative colitis. Cancer surveillance in an unselected population. Scand J Gastroenterol 1988;23:139-45.
24. Cannell WR, Lennard-Jones JE, Williams CB, et al. Factors affecting the outcome of endoscopic surveillance for cancer in ulcerative colitis. Gastroenterology 1994;107:934-44.
25. Lindberg B, Persson B, Veress B, et al. Twenty years' colonoscopic surveillance of patients with ulcerative colitis. Detection of dysplastic and malignant transformation. Scand J Gastroenterol 1996;31:1195-204.
26. Ullman TA, Loftus EV, Jr, Kakar S, et al. The fate of low grade dysplasia in ulcerative colitis. Am J Gastroenterol 2002;97:922-7.
27. Schlemper RJ, Riddell RH, Kato Y, et al. The Vienna classification of gastrointestinal epithelial neoplasia. Gut 2000;47:251-5.
28. Provenzale D, Kowdley KV, Arora S, et al. Prophylactic colectomy or surveillance for chronic ulcerative colitis? A decision analysis. Gastroenterology 1995;109:1188-96.
29. Rubin CE, Haggitt RC, Burmer GC, et al. DNA aneuploidy in colonic biopsies predicts future development of dysplasia in ulcerative colitis. Gastroenterology 1992;103:1611-20.
30. Johnson E, Carlsen E, Nazir M, et al. Morbidity and functional outcome after restorative proctocolectomy for ulcerative colitis. Eur J Surg 2001;167:40-5.
31. Tiainen J, Matikainen M. Long-term clinical outcome and anemia after restorative proctocolectomy for ulcerative colitis. Scand J Gastroenterol 2000;35:1170-3.